化学
前药
顺铂
程序性细胞死亡
劈开
癌症研究
细胞毒性
细胞凋亡
细胞生长
细胞
谷胱甘肽
化疗
结构-活动关系
肿瘤细胞
体外
二硫键
生物化学
膜透性
药理学
细胞培养
细胞存活
细胞生物学
小分子
胞浆
组合化学
硫醇
生物活性
作者
Jia-Le Liu,Zi-Han Zhao,Fan En-xi,Dan-Yang Wang,Zhi‐Hao You,Kan Yang,Longfei Li,Yali Song,Xueqing Song
标识
DOI:10.1021/acs.jmedchem.6c01905
摘要
Activation of single programmed cell death (PCD) pathway frequently contributes to the development of cisplatin (CP)-resistance. Herein, we designed and synthesized a series of carrier-free Pt(IV) nano-prodrugs designated CSPNPs (6aNPs−6dNPs). These prodrugs integrate three functional components into a single entity: CP as the core PCD-initiator; disulfide-cinnamic acid (CA) derivatives as amplifiers; and hydrophobic chains for self-assembly. Enriched in tumors via enhanced permeability and retention effect, CSPNPs cleave disulfide bonds and reduce Pt(IV) in high-glutathione (GSH) tumor microenvironment, depleting GSH and releasing active Pt(II) and CA-derivatives. This multi-pronged intervention blocks GSH-dependent cytoprotective hub and synergistically triggers p53-mediated apoptosis, GPX4-related ferroptosis and copper-driven cuproptosis. Compared with CP, the optimal 6bNPs gained 78.7% tumor inhibition in 4T1 xenograft-bearing mice, increased intratumoral Pt-content by 13.5-fold and alleviated systemic toxicity. This study establishes a viable paradigm beyond conventional CP-based chemotherapy and offers a generalizable strategy to enhance the inherent multi-pathway bioactivity of traditional chemotherapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI